MLK3 Signaling in Cancer Invasion

Chotirat Rattanasinchai1, Kathleen A Gallo2,3

  • 1Cell and Molecular Biology program, Michigan State University, East Lansing, MI 48824, USA. rattana1@msu.edu.

Cancers
|May 24, 2016
PubMed

Insights

Mixed-lineage kinase 3 (MLK3) is a key signaling molecule in cancer. MLK3 promotes cancer cell proliferation, migration, invasion, and metastasis through various downstream pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Mixed-lineage kinase 3 (MLK3) is a MAP3K that mediates signals from cell surface receptors.
  • MLK3's role in oncogenic signaling has gained recognition in the past decade.

Purpose of the Study:

  • To elucidate the role of MLK3 signaling in cancer.
  • To understand MLK3's downstream pathways and their contribution to oncogenesis.

Main Methods:

  • The study reviews existing literature on MLK3 signaling pathways.
  • Analysis of MLK3's interactions with receptor tyrosine kinases (RTKs), chemokine receptors, and cytokine receptors.

Main Results:

  • MLK3 activates downstream pathways including JNK, ERK, P38 MAPK, and NF-κB.
  • MLK3 signaling regulates both transcriptional and post-translational modifications of effector proteins.

Conclusions:

  • MLK3 signaling is implicated in promoting cancer cell proliferation.
  • MLK3 plays a significant role in driving cancer cell migration, invasion, and metastasis.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K